BioScience Health Innovations, Inc.
BHIC
$4.00
-$32.04-88.90%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.13M | 1.76M | 1.23M | 610.20K | 573.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.13M | 1.76M | 1.23M | 610.20K | 573.00K |
| Cost of Revenue | 433.20K | 683.00K | 330.90K | 271.20K | 148.20K |
| Gross Profit | 698.20K | 1.07M | 896.10K | 339.00K | 424.70K |
| SG&A Expenses | 707.00K | 616.80K | 469.30K | 329.10K | 368.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.14M | 1.30M | 800.30K | 600.30K | 516.80K |
| Operating Income | -8.80K | 457.70K | 426.80K | 10.00K | 56.20K |
| Income Before Tax | -8.80K | 457.70K | 426.80K | 10.00K | 56.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.80K | 457.70K | 426.80K | 10.00K | 56.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.80K | 457.70K | 426.80K | 10.00K | 56.20K |
| EBIT | -8.80K | 457.70K | 426.80K | 10.00K | 56.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.04 | 0.04 | 0.00 | 0.01 |
| Normalized Basic EPS | 0.00 | 0.03 | 0.02 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.04 | 0.04 | 0.00 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.03 | 0.02 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 10.98M | 10.98M | 10.98M | 10.66M | 10.47M |
| Average Diluted Shares Outstanding | 10.98M | 11.08M | 11.08M | 11.08M | 10.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |